Results 301 to 310 of about 327,068 (394)

Supplementary Material for: Effectiveness of mepolizumab in patients with severe eosinophilic asthma with/without nasal polyposis: a real-life study

, 2023
Bravo-Gutiérrez F.J., Juan Carlos Miralles-López, J. Valverde‐Molina, Alemany-Francés M.L., Rubén Andújar Espinosa, Manuel Castilla-Martínez, Avilés-Inglés M.J., Ana Mora-González, Pajarón-Fernández M.-J., Sheila Cabrejos-Perotti, José Meseguer-Arce, I Flores-Martín, Virginia Pérez‐Fernández, RE-ASGRAMUR GROUP   +13 more
openalex   +2 more sources

Risk of asthma in individuals with eosinophilic esophagitis: Population‐based cohort study with sibling analyses

Clinical and Translational Allergy, Volume 15, Issue 6, June 2025.
Abstract Introduction There are limited data on the relationship between eosinophilic esophagitis (EoE) and asthma. We aimed to assess the risk of asthma in EoE patients compared with matched controls and siblings. Methods Through the ESPRESSO study, a Swedish nationwide population‐based histopathology cohort, we identified EoE patients diagnosed ...
Niki Mitselou, Amiko Uchida, Bjorn Roelstraete, Erik Melén, John J. Garber, Jonas F. Ludvigsson   +5 more
wiley   +1 more source

Efficacy and safety of benralizumab in elderly patients with severe eosinophilic asthma. [PDF]

Eur Clin Respir J
Somekawa K, Watanabe K, Seki K, Muraoka S, Izawa A, Kaneko A, Otsu Y, Hirata M, Kubo S, Tanaka K, Nagasawa R, Matsumoto H, Murohashi K, Fuji H, Aoki A, Horita N, Hara Y, Kobayashi N, Kudo M, Kaneko T.   +19 more
europepmc   +1 more source

[Effectiveness of mepolizumab in patients with severe eosinophilic asthma: In a real life study]. [PDF]

Tuberk Toraks, 2023
Bulut İ, Yegin Katran Z, Yavuz D, Yıldız AB, Yakut T, Örçen C, Mersin SS.   +6 more
europepmc   +1 more source

Quality of life in type 2 and non‐type 2 endotypes in chronic rhinosinusitis with nasal polyps: A prospective trial

Clinical and Translational Allergy, Volume 15, Issue 6, June 2025.
Abstract Background In current clinical practice, primary diffuse chronic rhinosinusitis with nasal polyps (CRSwNP) is classified into two endotypes: type 2 and non‐type 2. Previous studies on sinonasal health‐related quality of life (HRQoL) in CRS have primarily focused on differences between phenotypes.
Stijn Bogaert, Elisabeth Rheindorf, Stefan Dazert, Stefan Volkenstein, Lisa Knipps, Jonas Jae‐Hyun Park, Oliver Pfaar   +6 more
wiley   +1 more source

Challenges With the Intolerance of Biologics in Severe Eosinophilic Asthma: The Risk of Exacerbations Is Time-Dependent With the Rise of Eosinophils. [PDF]

Cureus
Cortes-Telles A, Pou-Aguilar YN, Figueroa-Hurtado E, Vazquez-Lopez S, Ortiz DL.   +4 more
europepmc   +1 more source

Long-Term Real-World Outcomes of Mepolizumab and Benralizumab Among Biologic-Naive Patients With Severe Eosinophilic Asthma: Experience of 3 Years’ Therapy

, 2023
Fred Fyles, Amy Nuttall, Hannah Joplin, Hassan Burhan   +3 more
openalex   +2 more sources

Associations with food allergy‐related psychological distress in a global sample of adults, children and caregivers

Clinical and Translational Allergy, Volume 15, Issue 6, June 2025.
Abstract Objective Food allergy (FA) impacts health‐related quality of life and mental health. Understanding what variables are associated with psychological distress can help healthcare providers direct patients to appropriate support. As part of the study, Global Access to Psychological Services (GAPS) for FA and associations with FA‐related ...
S. E. M. Purser, C. J. Jones, J. L. P. Protudjer, L. J. Herbert, C. Screti, C. Roleston, E. Mattacola, H. A. Brough, C. Warren, L. Polloni, A. F. Santos, R. Gupta, M. J. Marchisotto, R. C. Knibb   +13 more
wiley   +1 more source

Long-Term Eosinophil Depletion: A Real-World Perspective on the Safety and Durability of Benralizumab Treatment in Severe Eosinophilic Asthma. [PDF]

J Clin Med
Menzella F, Marchi M, Caminati M, Romagnoli M, Micheletto C, Bonato M, Idotta G, Nizzetto M, D'Alba G, Cavenaghi M, Bortoli M, Beghè B, Pini L, Benoni R, Casoni G, Muzzolon R, Michieletto L, Bosi A, Mastrototaro A, Diamandi A, Nalin M, Senna G.   +21 more
europepmc   +1 more source

Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo. [PDF]

ERJ Open Res
Howell I, Bratton DJ, Hynes G, Yancey SW, Heaney LG, Pavord ID, Shrimanker R.   +6 more
europepmc   +1 more source